Michael W. Deininger, MD, PhD

    Michael W. Deininger, MD, PhD

    Professor and Chief of Hematology and Hematologic Malignancies
    Department of Internal Medicine and the Huntsman Cancer Institute
    University of Utah
    • Next Steps After TKIs for Patient With Chronic-Phase CML? Saturday, September 1st, 2018

      This month, Michael Deininger, MD, PhD, discusses treatment for a patient with chronic-phase chronic myeloid leukemia (CML) whose BCR/ABL transcript levels are rising. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!

    • How to treat an older patient with CML and a sudden ANC drop? Thursday, June 1st, 2017

      This month, Michael W. Deininger, MD, PhD, discusses myelosuppression in a patient with chronic myeloid leukemia. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!

    SHARE